|
시장보고서
상품코드
1786820
세계의 반려동물용 골관절염 시장 : 규모, 점유율, 동향, 산업 분석 보고서 - 동물별, 제품별, 투여 경로별, 최종 용도별, 지역별 시장 예측(2025-2034년)Companion Animal Osteoarthritis Market Size, Share, Trend, Industry Analysis Report By Animal (Canine, Equine, Feline), By Product, By Route of Administration, By End Use, By Region - Market Forecast, 2025-2034 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
Polaris Market Research의 최신 조사에 따르면, 반려동물용 골관절염 시장 규모는 2034년까지 184억 5,000만 달러에 이를 것으로 예측됩니다. 이 보고서는 현재 시장 역학을 상세하게 파악하고 미래 시장 성장에 대한 분석을 제공합니다.
반려동물용 골관절염 시장은 반려동물, 특히 개와 고양이의 퇴행성 관절 질환을 대상으로 하는 의료 솔루션에 대한 수요 증가에 대응하고 있습니다. 만성 및 진행성 질환인 골관절염은 고령화된 동물에서 운동 능력의 감소와 통증의 주요 원인이 되었습니다. 반려동물 주인의 의식이 높아지고, 수의사에 의한 진찰 증가, 진단 능력의 향상에 의해 시장은 기세를 늘리고 있습니다. 성장을 뒷받침하는 것은 치료 컴플라이언스 및 반려동물 삶의 질을 높이는 장기 작용 주사제와 항염증제와 같은 의약품 제제의 진보입니다.
수의사는 염증을 관리하고 관절 복구를 촉진하기 위해 다혈소판 혈장(PRP) 및 줄기 세포 용도와 같은 재생 요법을 통합합니다. 조기 개입과 다방면 통증 관리가 중시되고 약물, 영양 보충제 및 신체 재활을 포함한 병용 요법의 개발에 영향을 미칩니다. 시장 진출 기업은 다양한 위험 프로파일에 대응하는 비침습적인 선택과 견종에 특화된 솔루션을 요구하는 수요에 부응하고 있습니다. 활동 수준과 가동성을 모니터링하는 디지털 도구는 더 나은 치료 추적과 간병인의 참여를 가능하게 하는 보조 기술로 부상하고 있습니다. 예방 의학, 특히 관절 건강 보충제 및 시니어 반려동물을 위한 웰빙 계획의 개발은 여전히 비즈니스 기회가 확산되고 있습니다. 반려동물의 휴머니제이션(인간화) 동향 증가는 제조업체에게 안전성, 선호성, 증거를 바탕으로 한 효능을 우선하도록 촉구하고 있습니다. 진화하는 수의학적 지침과 수의사 클리닉과 제약 회사의 협력이 제품 혁신과 임상 채용을 촉진하고 있습니다.
반려동물용 골관절염 시장 보고서 하이라이트
제품별로, 생물학적 제형 부문은 단순히 증상을 완화할 뿐만 아니라 골관절염의 근본 원인을 표적으로 하는 능력이 있기 때문에 2024년 판매 점유율의 54%를 차지했습니다.
동물별로는 특히 고령의 대형 동물에서 골관절염 발생률이 높기 때문에 2024년에는 개 부문이 가장 큰 수익 점유율을 차지했습니다.
2024년에는 반려동물의 높은 의료 지출, 고급 수의학적 인프라, 반려동물의 만성 관절 질환에 대한 강한 인식으로 북미가 가장 큰 수익 점유율을 차지했습니다.
아시아태평양의 반려동물용 골관절염 시장은 반려동물 사육 증가, 중간 소득층 소득 확대, 동물 건강에 대한 의식 증가로 2025-2034년 크게 성장할 것으로 예측됩니다.
세계 주요 기업으로는 Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC., Elanco, Eltech K-Laser srl, NexGen Pharmaceuticals, Norbrook, Vetoquinol, Virbac, Zoetis 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 반려동물용 골관절염 시장 인사이트
- 시장 현황
- 반려동물용 골관절염 시장 역학
- 성장 촉진요인 및 기회
- 반려동물 사육 증가 및 인간화
- 수의사 정형외과 치료의 성장
- 성장 억제요인 및 과제
- 고액의 치료비
- 성장 촉진요인 및 기회
- PESTEL 분석
- 반려동물용 골관절염 시장 파워 평가의 동향
- 밸류체인 분석
제5장 반려동물용 골관절염 시장 : 제품별
- 주요 조사 결과
- 서문
- 생물학적 제형
- 점성 보충제
- 의약품
- 영양보조식품
제6장 반려동물용 골관절염 시장 : 동물별
- 주요 조사 결과
- 서문
- 개
- 말
- 고양이
- 기타
제7장 반려동물용 골관절염 시장 : 투여 경로별
- 주요 조사 결과
- 서문
- 경구
- 주사
- 기타
제8장 반려동물용 골관절염 시장 : 최종 용도별
- 주요 조사 결과
- 서문
- 동물병원 및 클리닉
- 전자상거래
- 기타
제9장 반려동물용 골관절염 시장 : 지역별
- 주요 조사 결과
- 서문
- 반려동물용 골관절염 시장 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 제품별(2020-2034년)
- 북미 : 동물별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 북미 : 투여 경로별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별(2020-2034년)
- 유럽 : 동물별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 유럽 : 투여 경로별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별(2020-2034년)
- 아시아태평양 : 동물별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 아시아태평양 : 투여 경로별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별(2020-2034년)
- 중동 및 아프리카 : 동물별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 중동 및 아프리카 : 투여 경로별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별(2020-2034년)
- 라틴아메리카 : 동물별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 라틴아메리카 : 투여 경로별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 확대 및 인수 분석
- 확대
- 인수
- 제휴, 협업, 합의 및 공개
제11장 기업 프로파일
- Boehringer Ingelheim International GmbH
- Ceva
- Dechra Pharmaceuticals PLC.
- Elanco
- Eltech K-Laser srl
- NexGen Pharmaceuticals
- Norbrook
- Vetoquinol
- Virbac
- Zoetis
The companion animal osteoarthritis market size is expected to reach USD 18.45 billion by 2034, according to a new study by Polaris Market Research. The report "Companion Animal Osteoarthritis Market Size, Share, Trend, Industry Analysis Report By Animal (Canine, Equine, Feline), By Product, By Route of Administration, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The companion animal osteoarthritis market addresses the growing demand for medical solutions targeting degenerative joint conditions in pets, particularly dogs and cats. Osteoarthritis, a chronic and progressive disease, is a leading cause of mobility loss and pain in aging animals. The market is gaining momentum due to increasing awareness among pet owners, a rise in veterinary consultations, and improved diagnostic capabilities. Growth is supported by advancements in pharmaceutical formulations, including long-acting injectable and anti-inflammatory medications that enhance treatment compliance and quality of life for pets.
Veterinarians are integrating regenerative therapies such as platelet-rich plasma (PRP) and stem cell applications to manage inflammation and promote joint repair. Increasing emphasis on early intervention and multimodal pain management is influencing the development of combination therapies involving drugs, dietary supplements, and physical rehabilitation. Market participants are responding to demand for noninvasive options and breed-specific solutions that address varying risk profiles. Digital tools for monitoring activity levels and mobility are emerging as supportive technologies, enabling better treatment tracking and caregiver engagement. Opportunities continue to grow in preventive care, particularly in the development of joint health supplements and wellness plans for senior pets. The rising trend of pet humanization is pushing manufacturers to prioritize safety, palatability, and evidence-based efficacy. Evolving veterinary guidelines and collaboration between veterinary practices and pharmaceutical companies are driving product innovation and clinical adoption.
Companion Animal Osteoarthritis Market Report Highlights
By product, the biologics segment accounted for ~54% of the revenue share in 2024 due to their ability to target the underlying causes of osteoarthritis rather than just alleviating symptoms.
Based on animal, the canine segment held the largest revenue share in 2024 due to the high incidence of osteoarthritis, particularly in aging and large-breed animals.
In 2024, North America accounted for the largest revenue share due to high pet healthcare spending, advanced veterinary infrastructure, and strong awareness of chronic joint conditions in companion animals.
The Asia Pacific companion animal osteoarthritis market is expected to grow significantly from 2025 to 2034 due to rising pet adoption, expanding middle-class income, and increasing awareness of animal health.
A few global key players include Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC., Elanco, Eltech K-Laser s.r.l., NexGen Pharmaceuticals, Norbrook, Vetoquinol, Virbac, and Zoetis.
Polaris Market Research has segmented the companion animal osteoarthritis market report on the basis of product, animal, route of administration, end use, and region:
By Product Outlook (Revenue, USD Billion, 2020-2034)
Biologics
Stem Cells
Platelet-Rich Plasma (PRP)
Monoclonal Antibodies (mAb)
Other Biologics
Viscosupplements
Pharmaceuticals
Steroids
NSAIDS
Others
Nutritional Supplements
By Animal Outlook (Revenue, USD Billion, 2020-2034)
Canine
Equine
Feline
By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)
Oral
Injectable
Others
By End Use Outlook (Revenue, USD Billion, 2020-2034)
Veterinary Hospitals/Clinics
E-commerce
Others
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Vietnam
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Companion Animal Osteoarthritis Market Insights
- 4.1. Companion Animal Osteoarthritis Market - Market Snapshot
- 4.2. Companion Animal Osteoarthritis Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increased Pet Ownership and Humanization
- 4.2.1.2. Growth in Veterinary Orthopaedic Treatments
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High treatment costs
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Companion Animal Osteoarthritis Market Power Rating Trends
- 4.6. Value Chain Analysis
5. Companion Animal Osteoarthritis Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Companion Animal Osteoarthritis Market, by Product, 2020-2034 (USD Billion)
- 5.3. Biologics
- 5.3.1. Companion Animal Osteoarthritis Market, by Biologics, by Region, 2020-2034 (USD Billion)
- 5.3.2. Stem Cells
- 5.3.2.1. Companion Animal Osteoarthritis Market, by Stem Cells, by Region, 2020-2034 (USD Billion)
- 5.3.3. Platelet-Rich Plasma (PRP)
- 5.3.3.1. Companion Animal Osteoarthritis Market, by Platelet-Rich Plasma (PRP), by Region, 2020-2034 (USD Billion)
- 5.3.4. Monoclonal Antibodies (mAb)
- 5.3.4.1. Companion Animal Osteoarthritis Market, by Monoclonal Antibodies (mAb), by Region, 2020-2034 (USD Billion)
- 5.3.5. Other Biologics
- 5.3.5.1. Companion Animal Osteoarthritis Market, by Other Biologics, by Region, 2020-2034 (USD Billion)
- 5.4. Viscosupplements
- 5.4.1. Companion Animal Osteoarthritis Market, by Viscosupplements, by Region, 2020-2034 (USD Billion)
- 5.5. Pharmaceuticals
- 5.5.1. Companion Animal Osteoarthritis Market, by Pharmaceuticals, by Region, 2020-2034 (USD Billion)
- 5.5.2. Steroids
- 5.5.2.1. Companion Animal Osteoarthritis Market, by Steroids, by Region, 2020-2034 (USD Billion)
- 5.5.3. NSAIDS
- 5.5.3.1. Companion Animal Osteoarthritis Market, by NSAIDS, by Region, 2020-2034 (USD Billion)
- 5.5.4. Others
- 5.5.4.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)
- 5.6. Nutritional Supplements
- 5.6.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)
6. Companion Animal Osteoarthritis Market, by Animal
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 6.3. Canine
- 6.3.1. Companion Animal Osteoarthritis Market, by Canine, by Region, 2020-2034 (USD Billion)
- 6.4. Equine
- 6.4.1. Companion Animal Osteoarthritis Market, by Equine, by Region, 2020-2034 (USD Billion)
- 6.5. Feline
- 6.5.1. Companion Animal Osteoarthritis Market, by Feline, by Region, 2020-2034 (USD Billion)
- 6.6. Others
- 6.6.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)
7. Companion Animal Osteoarthritis Market, by Route of Administration
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 7.3. Oral
- 7.3.1. Companion Animal Osteoarthritis Market, by Oral, by Region, 2020-2034 (USD Billion)
- 7.4. Injectable
- 7.4.1. Companion Animal Osteoarthritis Market, by Injectable, by Region, 2020-2034 (USD Billion)
- 7.5. Others
- 7.5.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)
8. Companion Animal Osteoarthritis Market, by End Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 8.3. Veterinary Hospitals/Clinics
- 8.3.1. Companion Animal Osteoarthritis Market, by Veterinary Hospitals/Clinics, by Region, 2020-2034 (USD Billion)
- 8.4. E-commerce
- 8.4.1. Companion Animal Osteoarthritis Market, by E-commerce, by Region, 2020-2034 (USD Billion)
- 8.5. Others
- 8.5.1. Companion Animal Osteoarthritis Market, by Others, by Region, 2020-2034 (USD Billion)
9. Companion Animal Osteoarthritis Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Companion Animal Osteoarthritis Market Assessment, By Geography, 2020-2034 (USD Billion)
- 9.3. Companion Animal Osteoarthritis Market - North America
- 9.3.1. North America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.3.2. North America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.3.3. North America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.3.4. North America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.3.5. Companion Animal Osteoarthritis Market - US
- 9.3.5.1. US: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.3.5.2. US: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.3.5.3. US: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.3.5.4. US: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.3.6. Companion Animal Osteoarthritis Market - Canada
- 9.3.6.1. Canada: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.3.6.2. Canada: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.3.6.3. Canada: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.3.6.4. Canada: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4. Companion Animal Osteoarthritis Market - Europe
- 9.4.1. Europe: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.4.2. Europe: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.4.3. Europe: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.4.4. Europe: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.5. Companion Animal Osteoarthritis Market - UK
- 9.4.5.1. UK: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.4.5.2. UK: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.4.5.3. UK: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.4.5.4. UK: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.6. Companion Animal Osteoarthritis Market - France
- 9.4.6.1. France: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.4.6.2. France: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.4.6.3. France: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.4.6.4. France: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.7. Companion Animal Osteoarthritis Market - Germany
- 9.4.7.1. Germany: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.4.7.2. Germany: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.4.7.3. Germany: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.4.7.4. Germany: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.8. Companion Animal Osteoarthritis Market - Italy
- 9.4.8.1. Italy: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.4.8.2. Italy: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.4.8.3. Italy: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.4.8.4. Italy: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.9. Companion Animal Osteoarthritis Market - Spain
- 9.4.9.1. Spain: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.4.9.2. Spain: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.4.9.3. Spain: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.4.9.4. Spain: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.10. Companion Animal Osteoarthritis Market - Netherlands
- 9.4.10.1. Netherlands: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.4.10.2. Netherlands: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.4.10.3. Netherlands: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.4.10.4. Netherlands: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.11. Companion Animal Osteoarthritis Market - Russia
- 9.4.11.1. Russia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.4.11.2. Russia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.4.11.3. Russia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.4.11.4. Russia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.4.12. Companion Animal Osteoarthritis Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5. Companion Animal Osteoarthritis Market - Asia Pacific
- 9.5.1. Asia Pacific: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.5. Companion Animal Osteoarthritis Market - China
- 9.5.5.1. China: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.5.5.2. China: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.5.5.3. China: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.5.5.4. China: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.6. Companion Animal Osteoarthritis Market - India
- 9.5.6.1. India: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.5.6.2. India: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.5.6.3. India: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.5.6.4. India: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.7. Companion Animal Osteoarthritis Market - Malaysia
- 9.5.7.1. Malaysia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.5.7.2. Malaysia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.5.7.3. Malaysia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.5.7.4. Malaysia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.8. Companion Animal Osteoarthritis Market - Japan
- 9.5.8.1. Japan: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.5.8.2. Japan: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.5.8.3. Japan: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.5.8.4. Japan: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.9. Companion Animal Osteoarthritis Market - Indonesia
- 9.5.9.1. Indonesia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.5.9.2. Indonesia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.5.9.3. Indonesia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.5.9.4. Indonesia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.10. Companion Animal Osteoarthritis Market - South Korea
- 9.5.10.1. South Korea: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.5.10.2. South Korea: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.5.10.3. South Korea: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.5.10.4. South Korea: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.11. Companion Animal Osteoarthritis Market - Australia
- 9.5.11.1. Australia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.5.11.2. Australia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.5.11.3. Australia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.5.11.4. Australia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.5.12. Companion Animal Osteoarthritis Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6. Companion Animal Osteoarthritis Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.5. Companion Animal Osteoarthritis Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.6. Companion Animal Osteoarthritis Market - UAE
- 9.6.6.1. UAE: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.6.6.2. UAE: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.6.6.3. UAE: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.6.6.4. UAE: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.7. Companion Animal Osteoarthritis Market - Israel
- 9.6.7.1. Israel: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.6.7.2. Israel: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.6.7.3. Israel: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.6.7.4. Israel: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.8. Companion Animal Osteoarthritis Market - South Africa
- 9.6.8.1. South Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.6.8.2. South Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.6.8.3. South Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.6.8.4. South Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.6.9. Companion Animal Osteoarthritis Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.7. Companion Animal Osteoarthritis Market - Latin America
- 9.7.1. Latin America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.7.5. Companion Animal Osteoarthritis Market - Mexico
- 9.7.5.1. Mexico: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.7.5.2. Mexico: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.7.5.3. Mexico: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.7.5.4. Mexico: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.7.6. Companion Animal Osteoarthritis Market - Brazil
- 9.7.6.1. Brazil: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.7.6.2. Brazil: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.7.6.3. Brazil: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.7.6.4. Brazil: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.7.7. Companion Animal Osteoarthritis Market - Argentina
- 9.7.7.1. Argentina: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.7.7.2. Argentina: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.7.7.3. Argentina: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.7.7.4. Argentina: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
- 9.7.8. Companion Animal Osteoarthritis Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Companion Animal Osteoarthritis Market, By Product, 2020-2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Companion Animal Osteoarthritis Market, By Animal, 2020-2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Companion Animal Osteoarthritis Market, by End Use, 2020-2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Companion Animal Osteoarthritis Market, by Route of Administration, 2020-2034 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Boehringer Ingelheim International GmbH
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Ceva
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Dechra Pharmaceuticals PLC.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Elanco
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Eltech K-Laser s.r.l.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. NexGen Pharmaceuticals
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Norbrook
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Vetoquinol
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Virbac
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Zoetis
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
샘플 요청 목록